Bullisch
$17.28
Szenariopreis
$28.855
+1.019 (+3.53%)Zum Schluss
Photronics, Inc. is a manufacturer of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. The Company manufactures photomasks, which are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates. The photomasks the Company manufactures incorporate circuit designs provided on a confidential basis by its customers. The Company sells its photomasks to semiconductor designers and manufacturers, and manufacturers of FPDs. Photomask technology is also being applied to the fabrication of other higher-performance electronic products such as virtual reality/augmented reality advanced IC packages, photonics, micro-electronic mechanical systems, and certain nanotechnology applications. The Company operates approximately 11 manufacturing facilities, which are located in Taiwan, China, Korea, the United States, and Europe.
Photronics Inc is currently not a strong buy due to its recent price performance and technical indicators. The current price is $28.15, with a low RSI of 39.83 indicating potential oversold conditions. However, the forward P/E ratio is 13.26, which is relatively low compared to the sector, suggesting that it could be undervalued. The stock has seen a significant insider selling increase of 1448.69% recently, which raises concerns about management's confidence in future performance. While the company has shown revenue growth and a gross margin improvement to 33.2%, the cautious Q4 revenue guidance of $207 million to $227 million reflects ongoing market uncertainties. Therefore, it is advisable to hold the stock for now and reassess after the next earnings report.
Freedom Broker
$41
2026-07-02
Freedom Broker
2026-07-02
Kursziel
$41
Lake Street
$55
2026-05-01
Lake Street
2026-05-01
Kursziel
$55
DA Davidson
$45
2025-12-11
DA Davidson
2025-12-11
Kursziel
$45
Craig-Hallum
$42
2025-12-11
Craig-Hallum
2025-12-11
Kursziel
$42
Craig-Hallum
$32
2025-06-11
Craig-Hallum
2025-06-11
Kursziel
$32
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

Faruqi & Faruqi Encourages Photronics Investors to Act

Hagens Berman Urges Investors to Contact Firm Over Losses

Reminder for Photronics Securities Class Action

Photronics Faces Class Action Lawsuit Over Securities Violations

Reminder for Photronics Securities Class Action
Photronics, Inc. is a manufacturer of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. The Company manufactures photomasks, which are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates. The photomasks the Company manufactures incorporate circuit designs provided on a confidential basis by its customers. The Company sells its photomasks to semiconductor designers and manufacturers, and manufacturers of FPDs. Photomask technology is also being applied to the fabrication of other higher-performance electronic products such as virtual reality/augmented reality advanced IC packages, photonics, micro-electronic mechanical systems, and certain nanotechnology applications. The Company operates approximately 11 manufacturing facilities, which are located in Taiwan, China, Korea, the United States, and Europe. It operates in the Technology sector (SEMICONDUCTORS & RELATED DEVICES industry).
Photronics Inc is currently not a strong buy due to its recent price performance and technical indicators. The current price is $28.15, with a low RSI of 39.83 indicating potential oversold conditions. However, the forward P/E ratio is 13.26, which is relatively low compared to the sector, suggesting that it could be undervalued. The stock has seen a significant insider selling increase of 1448.69% recently, which raises concerns about management's confidence in future performance. While the company has shown revenue growth and a gross margin improvement to 33.2%, the cautious Q4 revenue guidance of $207 million to $227 million reflects ongoing market uncertainties. Therefore, it is advisable to hold the stock for now and reassess after the next earnings report.
3 analysts cover PLAB: 1 rate it Buy, 2 Hold and 0 Sell.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.